Almoosa Health First Quarter 2025 Earnings: EPS Beats Expectations

Almoosa Health (TADAWUL:4018) First Quarter 2025 Results

Key Financial Results

• Revenue: ر.س323.0m (up 17% from 1Q 2024).
• Net income: ر.س51.1m (up 273% from 1Q 2024).
• Profit margin: 16% (up from 5.0% in 1Q 2024). The increase in margin was driven by higher revenue.
• EPS: ر.س1.17 (up from ر.س0.39 in 1Q 2024).

We check all companies for important risks. See what we found for Almoosa Health in our free report.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Almoosa Health EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 52%.

Looking ahead, revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Saudi Arabia.

Performance of the Saudi Healthcare industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Almoosa Health's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.